Enhancing Scale-Up, Increasing Quality, and Reducing Costs for AVs, LVVs, AAVs and More The 3rd Viral Vector Process Development and Manufacturing Summit returns to Boston, uniting industry leaders ...
OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised as a Champion in the ‘Cell & Gene Therapy’ category at the 2025 CDMO Leadership ...
Genezen has opened its new process development and analytical lab for viral vector production. Genezen, a cell and gene therapy contract development and manufacturing organization, has officially ...
Dutch artificial intelligence database startup Weaviate B.V. is looking to streamline the data vectorization process with a new feature that automatically transforms unstructured information into ...
The timely Viral Vector Formulation and Process Development Summit Europe is the only definitive, end-to-end platform, uniting 60+ experts across up-and downstream process development, formulation, ...
Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...
Vector is introducing PREEvision 9.0 – the next release of the software tool for developing distributed systems in the automotive industry and related areas. The model-based development environment is ...
Sources told DataRoom that the sale plans were on hold after Vector Meters was said to have lost a contract with EnergyAustralia to rival intellihub, placing the company in a position where it needed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback